We provide unique technology to revolutionise respiratory health

Inflammacheck®
ETL CoronaCheck®

We aim to make respiratory diseases measurable and more treatable

With our sophisticated and simple technology, we empower medical researchers and specialists to make advancements in healthcare through accurate, in-depth collection of respiratory data.
Based on normal, tidal breathing, researchers can collect all-in-one samples that are accurate and reliable – leading to better insights on lung inflammation levels and disease severity.

Not only that, our technology allows for multi-variable measurements and analysis, meaning researchers can measure a range of established biomarkers for further insights and investigation.

Pinpoint respiratory conditions with Inflammacheck®

For the first time, thanks to our simple to use and cutting-edge technology, physicians can pinpoint respiratory conditions through the measurement of hydrogen peroxide (H2O2)
in exhaled breath condensate.

With Inflammacheck®, advanced factory calibrated sensors monitor respiratory condition and inflammation through normal, tidal breathing. With our light-weight and simple design, tests can be carried out quickly and easily on all patients, regardless of the severity of their disease.

A game changing PoC screening device to be used at the frontline in the fight against coronavirus

CoronaCheck® is a development of an existing technology, the Inflammacheck®, which is the only device in the market designed to collect EBC and tests for compounds directly therein at PoC.

What we offer

Exhalation_985524096-768x495

Inflammacheck®

Thanks to our simple to use and cutting-edge technology, physicians can pinpoint respiratory conditions through the measurement of hydrogen peroxide (H2O2) in exhaled breath condensate. With Inflammacheck®, advanced factory calibrated sensors monitor respiratory condition and inflammation through normal, tidal breathing.
Read more
Photo by: Jon Klasbu (www.klasbu.no)

ETL CoronaCheck®

A rapid, reliable, non-invasive test for corona virus in exhaled breath. CoronaCheck® is a development of an existing technology, the Inflammacheck®, which is the only device in the market designed to collect EBC and tests for compounds directly therein at PoC. We, at Exhalation Medical Technology, have been granted a license to explore this opportunity.
Read more
Exhalation_503531836-768x512

Scientific Background

During chronic airway inflammation, the production of reactive oxygen species by activated inflammatory cells, resulting in oxidative stress. This can lead to further generation of inflammatory mediators, causing damage to epithelial cells, increased bronchial hyperreactivity and potentially aberrant growth of lung epithelial cells.
Read more